Correlation Between GlucoTrack and Predictive Oncology
Can any of the company-specific risk be diversified away by investing in both GlucoTrack and Predictive Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and Predictive Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlucoTrack and Predictive Oncology, you can compare the effects of market volatilities on GlucoTrack and Predictive Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of Predictive Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and Predictive Oncology.
Diversification Opportunities for GlucoTrack and Predictive Oncology
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between GlucoTrack and Predictive is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and Predictive Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Predictive Oncology and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with Predictive Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Predictive Oncology has no effect on the direction of GlucoTrack i.e., GlucoTrack and Predictive Oncology go up and down completely randomly.
Pair Corralation between GlucoTrack and Predictive Oncology
Given the investment horizon of 90 days GlucoTrack is expected to under-perform the Predictive Oncology. In addition to that, GlucoTrack is 2.12 times more volatile than Predictive Oncology. It trades about -0.22 of its total potential returns per unit of risk. Predictive Oncology is currently generating about 0.0 per unit of volatility. If you would invest 80.00 in Predictive Oncology on August 25, 2024 and sell it today you would lose (8.00) from holding Predictive Oncology or give up 10.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlucoTrack vs. Predictive Oncology
Performance |
| Timeline |
| GlucoTrack |
| Predictive Oncology |
GlucoTrack and Predictive Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlucoTrack and Predictive Oncology
The main advantage of trading using opposite GlucoTrack and Predictive Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, Predictive Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Predictive Oncology will offset losses from the drop in Predictive Oncology's long position.| GlucoTrack vs. Heartbeam | GlucoTrack vs. EUDA Health Holdings | GlucoTrack vs. Nutex Health | GlucoTrack vs. Healthcare Triangle |
| Predictive Oncology vs. Heartbeam | Predictive Oncology vs. EUDA Health Holdings | Predictive Oncology vs. Nutex Health | Predictive Oncology vs. Healthcare Triangle |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |